Tue.Jun 17, 2025

article thumbnail

When Innovation Outpaces Adoption, Patients Pay the Price

MedCity News

Robotics has already revolutionized fields like orthopedics and laparoscopic surgery. Endovascular care deserves the same leap forward. The technology exists. The evidence is strong. The challenge now is adoption. The post When Innovation Outpaces Adoption, Patients Pay the Price appeared first on MedCity News.

Patients 259
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

Two Democratic lawmakers have renewed accusations that large pharma companies have evaded paying U.S. taxes through a legislative loophole that drugmakers are allegedly lobbying to retain.

Pharma 207
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Wearables Are Changing the Way We Monitor Cancer Treatment

MedCity News

This ability to closely monitor patients remotely is redefining the standard of care, especially for those managing complex health conditions. RPM technology provides timely insights that allow healthcare teams to intervene early, improve patient outcomes, and reduce the burden on hospital resources. The post How Wearables Are Changing the Way We Monitor Cancer Treatment appeared first on MedCity News.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

Following HHS secretary Robert F. Kennedy Jr.’s decision last week to purge the CDC’s Advisory Committee on Immunization Practices and appoint his own replacements, the 17 ousted experts are hitting back at the arguments behind the cull.

145
145
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

AHIP CEO on the Budget Bill: “We Are Very Concerned About the Impact on Coverage”

MedCity News

During AHIP 2025, AHIP executives discussed the impact the proposed budget bill could have on Medicaid and the individual market. The post AHIP CEO on the Budget Bill: “We Are Very Concerned About the Impact on Coverage” appeared first on MedCity News.

Marketing 247
article thumbnail

FDA approves UroGen’s Zusduri to treat recurrent bladder cancer

PharmaTimes

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs FDA approves UroGen’s Zusduri to treat recurrent bladder cancer by Emily Kimber | 17th Jun 2025 | News Approximately 59,000 LG-IR-NMIBC patients experience recurrent disease every year in the US The US Food and Drug Administration (FDA) has approved UroGen Pharma’s Zusduri (mitomycin intravesical solutio

FDA 103

More Trending

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

With the FDA's approval of hereditary angioedema preventative treatment Andembry, CSL is ready to take on Takeda’s blockbuster Takhzyro and BioCryst Pharmaceuticals’ fast-rising Orladeyo in a competitive market to treat patients with the rare genetic condition.

article thumbnail

AI-powered orchestration: Bringing the benefits to personalized therapy

Pharmaceutical Technology

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient safety and regulatory compliance. AI can transform cell and gene therapy (CGT) orchestration by automating manual processes, improving productivity, enhancing supply chain visibility and improving scalability.

Safety 102
article thumbnail

Caris swells its planned IPO, seeking $5.7bn valuation

pharmaphorum

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -Wh

Media 88
article thumbnail

Changing the PAP Model

Pharmaceutical Commerce

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Genentech's Bittenbender named board chair at BIO

pharmaphorum

Genentech's Fritz Bittenbender becomes chair of the Biotechnology Innovation Organization at a challenging time for the sector.

90
article thumbnail

Biotech’s Broken Incentive: When Failure Makes CEOs Rich

World of DTC Marketing

One might assume that success—like bringing a life-saving drug to market—is the key to CEO wealth. But increasingly, we’re seeing the opposite: biotech executives are walking away with millions even as their companies flounder, burn through investor cash , and deliver little to no return for patients or shareholders. Welcome to the world where failure can be lucrative.

Retail 156
article thumbnail

23andMe fined £2.31m over UK users' genetic data breach

pharmaphorum

Genetic testing company 23andMe is facing a hefty fine from the UK's data protection watchdog for failing to protect its customers' data

75
article thumbnail

Patient Service Programs (PSPs): The New Brand Differentiator in Pharma

PM360

By Partha Anbil and Kamini Anbil Patient Service Programs (PSPs) have become a cornerstone for pharmaceutical brands, shaping patient outcomes and brand perception in today’s complex healthcare environment. The Rising Importance of PSPs Launching a new therapy now requires more than regulatory approval and clinical efficacy. With ongoing affordability challenges, increased payer scrutiny, and higher patient expectations, pharmaceutical companies are turning to comprehensive PSPs to ensure therap

article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Update: Rumour confirmed as Lilly buys Verve Therapeutics

pharmaphorum

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -Wh

Media 59
article thumbnail

European pharma needs scalable models to succeed in US

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Pharma 59
article thumbnail

Bolstering Health Technology Assessment With the Help of AI

Pharmaceutical Commerce

News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &

article thumbnail

Unlocking Brainpower: The AI-Driven Future of Medical Education for Pharma

Impetus Digital

Pharma-exclusive Webinar: Unlocking Brainpower: The AI-Driven Future of Medical Education for Pharma About the webinar Join Impetus Digital’s free webinar, September 23 & 24 , to discover how AI transforms learning, virtual activities, and insight gathering. We’ll unveil groundbreaking tools like our revolutionary AI Avatars , enabling hyper-realistic interactions, personalized training, and unprecedented insights.

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Communicate to Innovate: Five Communications Strategies Driving Biotech’s Future

PM360

Fresh from the World Orphan Drug Congress in Boston, it’s clear: biotechnology is not just advancing—it’s accelerating. The industry is evolving faster than ever, drawing upon groundbreaking technologies like AI (augmented implementation) and the growing promise of personalized medicine and gene splicing to treat illnesses once considered incurable.

Ethics 52
article thumbnail

Enhancing chromatographic protein purification with light

European Pharmaceutical Review

Researchers have demonstrated a generic affinity (bioaffinity) chromatography method that enables recombinant protein purification via UV light. Use of Excitography (light-controlled single-step protein purification) did not require “competing agents or harsh buffer conditions as is standard in these processes”. It operated “under native buffer conditions in a functional state and, optionally, in a high-throughput fashion”, Mayrhofer et al. explained.

Leads 52
article thumbnail

What Pharmaceutical HR looks for in Freshers?

Pharmatutor

What Pharmaceutical HR looks for in Freshers? Rajesh Vagh Tue, 06/17/2025 - 14:50 When hiring freshers, pharmaceutical HR departments aren’t just checking for a degree—they're trying to find someone who is ready to learn, able to follow strict guidelines, and can grow within the company. While experience may not be expected at this level, what really matters is the right attitude, a solid knowledge base, and basic practical exposure.

article thumbnail

Averoa secures EC authorisation for oral CKD treatment

Pharmaceutical Technology

The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney disease (CKD).

article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Legal Foundations for the Next Phase of Health AI Growth

Nixon Gwilt Law

Bringing a Health AI product to market is a major achievement—but growing that product successfully requires more than just technical or clinical validation. As your Health AI company enters new markets, adds features, and pursues larger customers or investors, the legal landscape grows more complex. In this post, we outline the legal groundwork you’ve likely already laid—and the key areas to prioritize next to ensure compliance, accelerate sales, and prepare for strategic growth.

article thumbnail

Pharma Pulse 6/17/25: How AI and Regulation are Reshaping the Future of Drug Safety; A Reflection on Our Path Forward

Pharmaceutical Commerce

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

In the latest episode of “The Next Marketing with HJ”, CMI's Mark Pappas decodes if your AI strategy is real innovation or just smoke and mirrors?

Marketing 122
article thumbnail

NextCure and Simcere partner to develop SIM0505 for solid tumours

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

New Company Chrysalis Launches After Acquisition of Cleanroom Assets

PharmaTech

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 pharmaceutical firms, and various other life sciences stakeholders.

article thumbnail

European biotech ecosystem takes aim at changing the funding narrative

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Media 59
article thumbnail

Tom Kraus on Top Advocacy Priorities for Pharmacists: 340B Protections, Payment Reform, and Grassroots Action

Pharmacy Times

From protecting the 340B Drug Pricing Program to expanding payment pathways through state-level reforms and Medicare Advantage opportunities, Kraus emphasized the critical role pharmacists play in evolving care models.

26
article thumbnail

Ex-ACIP panel warns of ‘critically weakened’ US immunisation programme

Pharmaceutical Technology

Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.

52
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.